{"id":"https://openalex.org/W2169754393","doi":"https://doi.org/10.6004/jnccn.2010.0115","title":"Complications of Multiple Myeloma Therapy, Part 1: Risk Reduction and Management of Peripheral Neuropathy and Asthenia","display_name":"Complications of Multiple Myeloma Therapy, Part 1: Risk Reduction and Management of Peripheral Neuropathy and Asthenia","publication_year":2010,"publication_date":"2010-02-01","ids":{"openalex":"https://openalex.org/W2169754393","doi":"https://doi.org/10.6004/jnccn.2010.0115","mag":"2169754393","pmid":"https://pubmed.ncbi.nlm.nih.gov/20141673"},"language":"en","primary_location":{"id":"doi:10.6004/jnccn.2010.0115","doi":"https://doi.org/10.6004/jnccn.2010.0115","is_oa":true,"landing_page_url":"https://doi.org/10.6004/jnccn.2010.0115","pdf_url":"https://jnccn.org/downloadpdf/view/journals/jnccn/8/Suppl_1/article-pS-4.pdf","source":{"id":"https://openalex.org/S935620192","display_name":"Journal of the National Comprehensive Cancer Network","issn_l":"1540-1405","issn":["1540-1405","1540-1413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4324004213","host_organization_name":"National Comprehensive Cancer","host_organization_lineage":["https://openalex.org/P4324004213"],"host_organization_lineage_names":["National Comprehensive Cancer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jnccn.org/downloadpdf/view/journals/jnccn/8/Suppl_1/article-pS-4.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. paul_richardson@dfci.harvard.edu","From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. paul_richardson@dfci.harvard.edu","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049711954","display_name":"Jacob P. Laubach","orcid":"https://orcid.org/0000-0001-7565-2052","observed_orcids":["https://orcid.org/0000-0001-7565-2052"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob P. Laubach","raw_affiliation_strings":["From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109183476","display_name":"Robert L Schlossman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert L. Schlossman","raw_affiliation_strings":["From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012712111","display_name":"Constantine S. Mitsiades","orcid":"https://orcid.org/0000-0003-2321-8005","observed_orcids":["https://orcid.org/0000-0003-2321-8005"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constantine Mitsiades","raw_affiliation_strings":["From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Anderson","raw_affiliation_strings":["From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6037,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.90723949,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"8","issue":"Suppl 1","first_page":"S","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.996999979019165},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/asthenia","display_name":"asthenia","score":0.7919999957084656},{"id":"https://openalex.org/keywords/treatment-side-effects","display_name":"treatment side effects","score":0.6729999780654907},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.8339999914169312},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.5860000252723694},{"id":"https://openalex.org/keywords/cumulative-dose","display_name":"cumulative dose","score":0.7279999852180481},{"id":"https://openalex.org/keywords/screening-and-monitoring","display_name":"screening and monitoring","score":0.703000009059906},{"id":"https://openalex.org/keywords/patient-education","display_name":"patient education","score":0.8960000276565552},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7329999804496765},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9851257801055908},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.809345006942749},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6380685567855835},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6120003461837769},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5719206929206848},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5627062320709229},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5494968295097351},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4487890899181366},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3297790288925171},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.06322881579399109},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001247","descriptor_name":"Asthenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001247","descriptor_name":"Asthenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012308","descriptor_name":"Risk Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D040242","descriptor_name":"Risk Reduction Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.6004/jnccn.2010.0115","doi":"https://doi.org/10.6004/jnccn.2010.0115","is_oa":true,"landing_page_url":"https://doi.org/10.6004/jnccn.2010.0115","pdf_url":"https://jnccn.org/downloadpdf/view/journals/jnccn/8/Suppl_1/article-pS-4.pdf","source":{"id":"https://openalex.org/S935620192","display_name":"Journal of the National Comprehensive Cancer Network","issn_l":"1540-1405","issn":["1540-1405","1540-1413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4324004213","host_organization_name":"National Comprehensive Cancer","host_organization_lineage":["https://openalex.org/P4324004213"],"host_organization_lineage_names":["National Comprehensive Cancer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network","raw_type":"journal-article"},{"id":"pmid:20141673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20141673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network : JNCCN","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.6004/jnccn.2010.0115","doi":"https://doi.org/10.6004/jnccn.2010.0115","is_oa":true,"landing_page_url":"https://doi.org/10.6004/jnccn.2010.0115","pdf_url":"https://jnccn.org/downloadpdf/view/journals/jnccn/8/Suppl_1/article-pS-4.pdf","source":{"id":"https://openalex.org/S935620192","display_name":"Journal of the National Comprehensive Cancer Network","issn_l":"1540-1405","issn":["1540-1405","1540-1413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4324004213","host_organization_name":"National Comprehensive Cancer","host_organization_lineage":["https://openalex.org/P4324004213"],"host_organization_lineage_names":["National Comprehensive Cancer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2169754393.pdf","grobid_xml":"https://content.openalex.org/works/W2169754393.grobid-xml"},"referenced_works_count":59,"referenced_works":["https://openalex.org/W130455168","https://openalex.org/W144127422","https://openalex.org/W281780641","https://openalex.org/W596674826","https://openalex.org/W1506957333","https://openalex.org/W1841854979","https://openalex.org/W1849465420","https://openalex.org/W1867927052","https://openalex.org/W1972122283","https://openalex.org/W1983597383","https://openalex.org/W1987710106","https://openalex.org/W1988898930","https://openalex.org/W1989740966","https://openalex.org/W1989900088","https://openalex.org/W1992538067","https://openalex.org/W1993714077","https://openalex.org/W2000384927","https://openalex.org/W2009883708","https://openalex.org/W2010553151","https://openalex.org/W2017303578","https://openalex.org/W2020778579","https://openalex.org/W2021954218","https://openalex.org/W2026742920","https://openalex.org/W2027913637","https://openalex.org/W2035035521","https://openalex.org/W2036139631","https://openalex.org/W2037503266","https://openalex.org/W2039099638","https://openalex.org/W2041884524","https://openalex.org/W2050504180","https://openalex.org/W2052498561","https://openalex.org/W2064451393","https://openalex.org/W2068215955","https://openalex.org/W2076730692","https://openalex.org/W2094310013","https://openalex.org/W2096207943","https://openalex.org/W2099646209","https://openalex.org/W2107154392","https://openalex.org/W2107252423","https://openalex.org/W2108235071","https://openalex.org/W2118820477","https://openalex.org/W2120940824","https://openalex.org/W2124560610","https://openalex.org/W2127760782","https://openalex.org/W2129534936","https://openalex.org/W2142149038","https://openalex.org/W2147769421","https://openalex.org/W2148188974","https://openalex.org/W2150471053","https://openalex.org/W2167041167","https://openalex.org/W2172122039","https://openalex.org/W2398770551","https://openalex.org/W2413642590","https://openalex.org/W2466001895","https://openalex.org/W2555603866","https://openalex.org/W2564026069","https://openalex.org/W2565146370","https://openalex.org/W2577615809","https://openalex.org/W2580695821"],"related_works":["https://openalex.org/W2117237065","https://openalex.org/W1973410606","https://openalex.org/W1762081208","https://openalex.org/W2167041167","https://openalex.org/W1972580468","https://openalex.org/W4386172088","https://openalex.org/W2473107683","https://openalex.org/W2156422872","https://openalex.org/W4405729191","https://openalex.org/W2098422029"],"abstract_inverted_index":{"Peripheral":[0],"neuropathy":[1],"(PN)":[2],"and":[3,10,44,73,96,107,113],"asthenia":[4,74],"(fatigue)":[5],"occur":[6],"as":[7,125,127],"both":[8],"disease-":[9],"treatment-related":[11,22,123],"complications":[12],"in":[13,60],"patients":[14,34,66],"with":[15,35,91,110],"multiple":[16],"myeloma":[17],"(MM).":[18],"Risk":[19],"factors":[20],"for":[21],"PN,":[23],"which":[24],"has":[25],"an":[26],"estimated":[27],"incidence":[28],"of":[29,47,57,65,71,94,103,121],"37%":[30],"to":[31,63,79],"83%":[32],"among":[33],"MM,":[36],"include":[37],"therapy":[38,95],"duration,":[39],"dose":[40,86],"intensity,":[41],"cumulative":[42],"dose,":[43],"the":[45,52,119],"presence":[46],"preexisting":[48],"neuropathy.":[49],"Asthenia":[50],"is":[51],"most":[53],"common":[54],"adverse":[55],"effect":[56],"treatment,":[58],"occurring":[59],"approximately":[61],"76%":[62],"96%":[64],"receiving":[67],"therapy.":[68],"The":[69],"severity":[70],"PN":[72],"can":[75,84,117],"range":[76],"from":[77],"mild":[78],"potentially":[80],"debilitating.":[81],"These":[82],"conditions":[83],"be":[85],"limiting;":[87],"they":[88],"may":[89,97],"interfere":[90],"optimizing":[92],"duration":[93],"also":[98],"substantially":[99],"affect":[100],"patient":[101,111],"quality":[102],"life.":[104],"Regular":[105],"screening":[106],"monitoring,":[108],"combined":[109],"education":[112],"effective":[114],"management":[115],"strategies,":[116],"reduce":[118],"risk":[120],"these":[122],"complications,":[124],"well":[126],"their":[128],"consequences.":[129]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}